An Open-Label, Single Sequence, Three-Period Drug Interaction Study of GSK1349572 and Tipranavir/Ritonavir in Healthy Adult Subjects (ING113096).

Trial Profile

An Open-Label, Single Sequence, Three-Period Drug Interaction Study of GSK1349572 and Tipranavir/Ritonavir in Healthy Adult Subjects (ING113096).

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2011

At a glance

  • Drugs Dolutegravir; Ritonavir; Tipranavir
  • Indications HIV infections; HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 24 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 20 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top